Skip to main content
Novartis
language-selector-globe
Choose location
language-selector-globe Canada |
EnglishFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe
Choose location
language-selector-globeCanada
EnglishFrançais
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Canada 
        • Novartis Biome in Canada 
      • Diversity, Equity and Inclusion 
      • Executive Committee 
      • People and Culture 
      • Therapeutic Areas 
      • Products 
      • Our people Stories 
      • Contact Us 
      Woman and man looking at laptop
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Patient perspective Stories 
      • Grants and Donations 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • HCP Portal 
      • Products 
      • Pipeline (EN) 
      • Adverse Event Reporting 
      • Clinical Trials 
      • Novartis Clinical Trials 
      • Disclosure Of Payments To Healthcare Professionals 
      Healthcare Professionals Header Image
      Healthcare Professionals
    • ESG 
      • Access 
      • Ethics, Risk and Compliance 
      • Grants and Donations 
      • Health Equity Initiative 
        • Guidelines and Eligibility Criteria 
        • About the Novartis Health Equity Initiative 
        • Health Equity in Canada 
        • Online Application 
      • Corporate Responsibility 
        • AODA Compliant - EN (PDF 0.2 MB) 
        • AODA Compliant - FR (PDF 0.2 MB) 
        • AMA Compliant - EN (PDF 0.2 MB) 
        • AMA Compliant - FR (PDF 0.2 MB)  
        • Disclosure Of Payments To Healthcare Professionals 
        • Environmental Sustainability 
      • Reporting and Transparency Hub 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Our people Stories 
      • Website Privacy Policy 
      • General Privacy Notice for Business Partners 
      • General Privacy Notice for Third Parties 
      • General Privacy Notice for External Stakeholders 
      • Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints " 
    • Careers 
      • Diversity, Equity and Inclusion 
      • People and Culture 
      • Career Search 
      • How We Work 
      • Well-being 
      Two women chatting
      Careers
    • Contact Us 
Header
Woman and man looking at laptop

Novartis Canada

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Family walking in park

Novartis in Canada

As a leading healthcare company, Novartis provides Canadians with medicines to improve their health and quality of life, focusing on areas of significant unmet medical need.

Two Novartis associates walking up a set of stairs

Diversity, Equity and Inclusion

We want to build a diverse and inclusive workplace where every one of us can be our best and true selves, so that together we can discover more, reach underserved communities and reimagine medicine.

People and culture

People and Culture

We must fundamentally reimagine the way we work and create a culture that brings out the best in our people to fulfill our purpose of reimagining medicine to improve and extend people’s lives.

Gloved hand holding vial

Products

A list of the treatments we currently offer via our Innovative Medicines Division.

Break room with tables

Contact

Find information on our research locations and corporate offices in Canada.

Novartis Canada

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis Websites
  • Global site
  • HCP Portal
Footer Bottom
© 2025 Novartis AG
  • Terms of Use
  • Privacy
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Canada.